- Exchange: New York
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Large Pharmaceuticals
Bristol-Myers Squibb Co
+ Add to WatchlistBMY:US
46.8500 USD 0.4100 0.88%As of 20:04:08 ET on 06/18/2013.
Snapshot for Bristol-Myers Squibb Co (BMY)
| Open: | 46.6000 | Day's Range: | 46.4600 - 47.0000 | Volume: | 7,155,486 |
|---|---|---|---|---|---|
| Previous Close: | 46.4400 | 52wk Range: | 30.6400 - 49.5700 | 1-Yr Rtn: | +39.85% |
Key Statistics for BMY
| Current P/E Ratio (ttm) | 26.0238 |
|---|---|
| Estimated P/E(12/2013) | 25.6853 |
| Relative P/E vs. SPX | 1.6113 |
| Earnings Per Share (USD) (ttm) | 1.8003 |
| Est. EPS (USD) (12/2013) | 1.8240 |
| Est. PEG Ratio | 3.3734 |
| Market Cap (M USD) | 76,953.55 |
| Shares Outstanding (M) | 1,642.55 |
| 30 Day Average Volume | 12,907,130 |
| Price/Book (mrq) | 5.6080 |
| Price/Sale (ttm) | 4.7950 |
| Dividend Indicated Gross Yield | 2.99% |
| Cash Dividend (USD) | 0.3500 |
| Last Dividend | 04/03/2013 |
| 5 Year Dividend Growth | 3.18% |
| Next Earnings Announcement | 07/25/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for BMY
Company Profile & Key Executives for BMY
Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.
| Lamberto AndreottiChief Executive Officer | Francis CussSenior VP:Research & Dev |
| Louis S SchmuklerPres:Global Manufacturing | Giovanni CaforioPres:US Pharmaceuticals |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
BMY News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page